Basal-bolus insulin versus sliding scale insulin for managing blood sugar levels in hospitalized diabetic patients

Not Applicable

Recruiting

• Conditions: Inpatient blood glucose management; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12609000336280
• Lead Sponsor: Repatriation General Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-05-22
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 158

Inclusion Criteria

Any diabetic patient admitted to the hospital requiring either basal-bolus insulin or sliding scale insulin for intensification of glycaemic control.

Exclusion Criteria

None

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mean daily blood glucose. This is taken by using the mean of the routine four times daily capillary blood glucose readings taken by nursing staff for each patient, using a standardized point-of-care glucometer. The study is powered to detect a mean daily difference of 2mmol/L.Comparison will be via Student t-test[Capillary blood glucose performed four times daily. Patients maintained on either basal-bolus or sliding scale at doctors discretion, usually 3-14 days.]

Secondary Outcome Measures

Name	Time	Method
Daily proportion of blood glucose readings in desirable range (4-10mmol/L).This is calculated by utilising the routine four times daily capillary blood glucose readings taken by nursing staff for each patient, using a standardized point-of-care glucometer. Comparison will be via Chi-square.[Capillary blood glucose performed four times daily. Patients maintained on either basal-bolus or sliding scale at doctors discretion, usually 3-14 days.]